company background image
CHEMM logo

ChemoMetec CPSE:CHEMM Stock Report

Last Price

kr.301.00

Market Cap

kr.5.2b

7D

-4.5%

1Y

-36.0%

Updated

23 Jun, 2024

Data

Company Financials +

CHEMM Stock Overview

Engages in the development, production, and sale of analytical equipment for cell counting and analysis the United States, Canada, Europe, and internationally.

CHEMM fundamental analysis
Snowflake Score
Valuation1/6
Future Growth3/6
Past Performance3/6
Financial Health6/6
Dividends2/6

ChemoMetec A/S Competitors

Price History & Performance

Summary of all time highs, changes and price drops for ChemoMetec
Historical stock prices
Current Share Pricekr.301.00
52 Week Highkr.554.00
52 Week Lowkr.255.00
Beta1.26
11 Month Change-17.89%
3 Month Change-29.18%
1 Year Change-35.98%
33 Year Change-63.69%
5 Year Change90.51%
Change since IPO1,268.18%

Recent News & Updates

Recent updates

Some Confidence Is Lacking In ChemoMetec A/S (CPH:CHEMM) As Shares Slide 32%

Apr 15
Some Confidence Is Lacking In ChemoMetec A/S (CPH:CHEMM) As Shares Slide 32%

What ChemoMetec A/S' (CPH:CHEMM) 30% Share Price Gain Is Not Telling You

Mar 01
What ChemoMetec A/S' (CPH:CHEMM) 30% Share Price Gain Is Not Telling You

What Does ChemoMetec A/S's (CPH:CHEMM) Share Price Indicate?

Mar 01
What Does ChemoMetec A/S's (CPH:CHEMM) Share Price Indicate?

Earnings Beat: ChemoMetec A/S Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Feb 08
Earnings Beat: ChemoMetec A/S Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Unpleasant Surprises Could Be In Store For ChemoMetec A/S' (CPH:CHEMM) Shares

Dec 21
Unpleasant Surprises Could Be In Store For ChemoMetec A/S' (CPH:CHEMM) Shares

Is It Time To Consider Buying ChemoMetec A/S (CPH:CHEMM)?

Nov 15
Is It Time To Consider Buying ChemoMetec A/S (CPH:CHEMM)?

ChemoMetec A/S (CPH:CHEMM) Consensus Forecasts Have Become A Little Darker Since Its Latest Report

Sep 17
ChemoMetec A/S (CPH:CHEMM) Consensus Forecasts Have Become A Little Darker Since Its Latest Report

A Look At The Intrinsic Value Of ChemoMetec A/S (CPH:CHEMM)

Sep 15
A Look At The Intrinsic Value Of ChemoMetec A/S (CPH:CHEMM)

At kr.467, Is ChemoMetec A/S (CPH:CHEMM) Worth Looking At Closely?

Jun 20
At kr.467, Is ChemoMetec A/S (CPH:CHEMM) Worth Looking At Closely?

With EPS Growth And More, ChemoMetec (CPH:CHEMM) Makes An Interesting Case

Jun 01
With EPS Growth And More, ChemoMetec (CPH:CHEMM) Makes An Interesting Case

Here's Why ChemoMetec (CPH:CHEMM) Has Caught The Eye Of Investors

Jan 24
Here's Why ChemoMetec (CPH:CHEMM) Has Caught The Eye Of Investors

If EPS Growth Is Important To You, ChemoMetec (CPH:CHEMM) Presents An Opportunity

Oct 26
If EPS Growth Is Important To You, ChemoMetec (CPH:CHEMM) Presents An Opportunity

Is It Time To Consider Buying ChemoMetec A/S (CPH:CHEMM)?

Oct 05
Is It Time To Consider Buying ChemoMetec A/S (CPH:CHEMM)?

Does ChemoMetec (CPH:CHEMM) Deserve A Spot On Your Watchlist?

Jul 18
Does ChemoMetec (CPH:CHEMM) Deserve A Spot On Your Watchlist?

Here's Why I Think ChemoMetec (CPH:CHEMM) Is An Interesting Stock

Mar 27
Here's Why I Think ChemoMetec (CPH:CHEMM) Is An Interesting Stock

Do ChemoMetec's (CPH:CHEMM) Earnings Warrant Your Attention?

Dec 12
Do ChemoMetec's (CPH:CHEMM) Earnings Warrant Your Attention?

Here's Why I Think ChemoMetec (CPH:CHEMM) Might Deserve Your Attention Today

Aug 29
Here's Why I Think ChemoMetec (CPH:CHEMM) Might Deserve Your Attention Today

Here's Why I Think ChemoMetec (CPH:CHEMM) Might Deserve Your Attention Today

Apr 28
Here's Why I Think ChemoMetec (CPH:CHEMM) Might Deserve Your Attention Today

ChemoMetec A/S' (CPH:CHEMM) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?

Mar 18
ChemoMetec A/S' (CPH:CHEMM) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?

ChemoMetec (CPH:CHEMM) Is Growing Earnings But Are They A Good Guide?

Feb 10
ChemoMetec (CPH:CHEMM) Is Growing Earnings But Are They A Good Guide?

What Type Of Shareholders Make Up ChemoMetec A/S' (CPH:CHEMM) Share Registry?

Jan 15
What Type Of Shareholders Make Up ChemoMetec A/S' (CPH:CHEMM) Share Registry?

Do ChemoMetec's (CPH:CHEMM) Earnings Warrant Your Attention?

Dec 20
Do ChemoMetec's (CPH:CHEMM) Earnings Warrant Your Attention?

ChemoMetec A/S' (CPH:CHEMM) Has Had A Decent Run On The Stock market: Are Fundamentals In The Driver's Seat?

Nov 22
ChemoMetec A/S' (CPH:CHEMM) Has Had A Decent Run On The Stock market: Are Fundamentals In The Driver's Seat?

Shareholder Returns

CHEMMDK Life SciencesDK Market
7D-4.5%-3.9%0.06%
1Y-36.0%-15.6%39.6%

Return vs Industry: CHEMM underperformed the Danish Life Sciences industry which returned -15.6% over the past year.

Return vs Market: CHEMM underperformed the Danish Market which returned 39.6% over the past year.

Price Volatility

Is CHEMM's price volatile compared to industry and market?
CHEMM volatility
CHEMM Average Weekly Movement8.7%
Life Sciences Industry Average Movement6.0%
Market Average Movement4.4%
10% most volatile stocks in DK Market9.8%
10% least volatile stocks in DK Market2.8%

Stable Share Price: CHEMM's share price has been volatile over the past 3 months.

Volatility Over Time: CHEMM's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of Danish stocks.

About the Company

FoundedEmployeesCEOWebsite
1997171Martin Behrenschemometec.com

ChemoMetec A/S engages in the development, production, and sale of analytical equipment for cell counting and analysis the United States, Canada, Europe, and internationally. The company offers its solutions in are areas of cell-based therapy, cancer, and stem cell research, development, and manufacturing of pharmaceuticals as well as production and quality control of animal semen and beer. Its products include NucleoCounter NC-3000, an advanced image cytometer; NucleoCounter NC-250, an automated cell analyzer; NucleoCounter NC-202, a consistent cell counter; NucleoCounter NC-200, an automated cell counter that provides solution for cell counting and cell viability determination; NucleoCounter SP-100, an automated sperm cell counter for use in animal reproduction; NucleoCounter SCC-100, a somatic cell counter used to measure the number of somatic cells in a milk sample; and NucleoCounter YC-100, an automated yeast cell counter used to measure the total cell count and viability of yeast cells in suspension.

ChemoMetec A/S Fundamentals Summary

How do ChemoMetec's earnings and revenue compare to its market cap?
CHEMM fundamental statistics
Market capkr.5.24b
Earnings (TTM)kr.143.80m
Revenue (TTM)kr.401.54m

36.4x

P/E Ratio

13.0x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
CHEMM income statement (TTM)
Revenuekr.401.54m
Cost of Revenuekr.47.43m
Gross Profitkr.354.11m
Other Expenseskr.210.31m
Earningskr.143.80m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

Sep 11, 2024

Earnings per share (EPS)8.26
Gross Margin88.19%
Net Profit Margin35.81%
Debt/Equity Ratio0.2%

How did CHEMM perform over the long term?

See historical performance and comparison

Dividends

2.0%

Current Dividend Yield

73%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.